olivLaw · US equity research
ICL Group Ltd. ICL
Agricultural Chemicals · SIC 2870 · Vertical: Agricultural Chemicals (SIC 2870)
ICL Group Ltd. is a global leader in agriculture, food and industrial solutions, built on its own mineral resources in the Dead Sea, Spain, Israel and the United Kingdom. The company focuses on specialty agriculture and food businesses, at a time when food security and access to essential minerals remain central themes. Total sales for fiscal 2025 were 7153 million USD.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, ICL Group Ltd. (ICL) stock was 4.58 USD (+5.05% on the day), with market capitalisation 5.9 bn USD, P/E 25.4 on diluted EPS of 0.18 USD over the last 12 months, dividend yield 3.79%, beta 0.68, 52-week range 4.36–6.82 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 37.8
- weak (30–45)
- Bollinger (20, 2)
- 4.43 – 5.16
- in the lower half of the band · %B 0.21 · band width 15.3%
- SMA 50 / 200
- 5.20 / 5.38
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.18 / -0.16
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −9.5% | −1.1% | −8.4 pp | — |
| 3 months | −12.4% | −0.5% | −12.0 pp | — |
| 6 months | −18.5% | +4.4% | −22.9 pp | — |
| Year to date | −19.8% | +12.3% | −32.1 pp | — |
| 1 year | −30.5% | +13.5% | −44.0 pp | −10.3% |
| 3 years | −8.2% | +76.4% | −84.6 pp | −63.6% |
| 5 years | −48.1% | +63.7% | −111.7 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 78 percentile of its own 9-quarter history (min 4.4, median 13.9, max 505.0; quarters with earnings only).
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.6 bn | 5.3 bn | 5.0 bn | 7.0 bn | 10.0 bn | 7.5 bn | 6.8 bn | 7.2 bn |
| Revenue YoY | +2.5% | −5.1% | −4.3% | +37.9% | +44.0% | −24.8% | −9.2% | +4.6% |
| Net income | 1.2 bn | 475.0 m | 11.0 m | 783.0 m | 2.2 bn | 647.0 m | 407.0 m | 226.0 m |
| Net income YoY | +240.7% | −61.7% | −97.7% | +7,018.2% | +175.7% | −70.0% | −37.1% | −44.5% |
| Diluted EPS | 0.97 | 0.37 | 0.01 | 0.60 | 1.67 | 0.50 | 0.32 | 0.18 |
| Diluted EPS YoY | +234.5% | −61.9% | −97.3% | +5,900.0% | +178.3% | −70.1% | −36.0% | −43.8% |
| net % | 22.3% | 9.0% | 0.2% | 11.3% | 21.6% | 8.6% | 5.9% | 3.2% |
| Free cash flow | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 291.0 m USD
- Financial debt
- 2.8 bn USD
- Net debt
- 2.5 bn USD
- Equity
- 6.2 bn USD
- Total assets
- 12.4 bn USD
- Debt / equity
- 0.44x
- Current ratio
- 1.33x
- ROE
- 3.7%
- ROA
- 1.9%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 5.0 bn | 7.0 bn | 10.0 bn | 7.5 bn | 6.8 bn | 7.2 bn | SEC (XBRL)· 11 Mar 2026verified |
| Cost of revenue | 3.6 bn | 4.3 bn | 5.0 bn | 4.9 bn | 4.6 bn | 5.0 bn | SEC (XBRL)· 11 Mar 2026verified |
| Gross profit | 1.5 bn | 2.6 bn | 5.0 bn | 2.7 bn | 2.3 bn | 2.2 bn | SEC (XBRL)· 11 Mar 2026verified |
| Research & development | 54.0 m | 64.0 m | 68.0 m | 71.0 m | 69.0 m | 70.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Operating income | 202.0 m | 1.2 bn | 3.5 bn | 1.1 bn | 775.0 m | 580.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Depreciation & amortisation | 579.0 m | 484.0 m | 498.0 m | 536.0 m | 610.0 m | 726.0 m | SEC (XBRL)· 11 Mar 2026verified |
| EBITDA | 781.0 m ≈ | 1.7 bn ≈ | 4.0 bn ≈ | 1.7 bn ≈ | 1.4 bn ≈ | 1.3 bn ≈ | SEC (XBRL)· 11 Mar 2026derived |
| Interest expense | 219.0 m | 216.0 m | 327.0 m | 259.0 m | 181.0 m | 298.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Pre-tax income | 49.0 m | 1.1 bn | 3.4 bn | 974.0 m | 636.0 m | 441.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Income tax | 25.0 m | 260.0 m | 1.2 bn | 287.0 m | 172.0 m | 161.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Net income | 11.0 m | 783.0 m | 2.2 bn | 647.0 m | 407.0 m | 226.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Diluted EPS | 0.01 | 0.60 | 1.67 | 0.50 | 0.32 | 0.18 | SEC (XBRL)· 11 Mar 2026verified |
| Weighted average diluted shares | 1.3 bn | 1.3 bn | 1.3 bn | 1.3 bn | 1.3 bn | 1.3 bn | SEC (XBRL)· 11 Mar 2026verified |
| Dividend per share | 0.09 | 0.21 | 0.90 | 0.36 | 0.19 | 0.17 | SEC (XBRL)· 11 Mar 2026derived |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 214.0 m | 473.0 m | 417.0 m | 420.0 m | 327.0 m | 291.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Inventories | 1.3 bn | 1.6 bn | 2.1 bn | 1.7 bn | 1.6 bn | 1.9 bn | SEC (XBRL)· 11 Mar 2026verified |
| Current assets | 2.8 bn | 3.9 bn | 4.5 bn | 4.0 bn | 3.6 bn | 4.2 bn | SEC (XBRL)· 11 Mar 2026verified |
| Property, plant & equipment, net | 5.6 bn | 5.8 bn | 6.0 bn | 6.3 bn | 6.5 bn | 6.8 bn | SEC (XBRL)· 11 Mar 2026verified |
| Total assets | 9.7 bn | 11.1 bn | 11.8 bn | 11.6 bn | 11.3 bn | 12.4 bn | SEC (XBRL)· 11 Mar 2026verified |
| Accounts payable | 740.0 m | 1.1 bn | 1.0 bn | 912.0 m | 1.0 bn | 1.2 bn | SEC (XBRL)· 11 Mar 2026verified |
| Short-term debt | 679.0 m | 577.0 m | 512.0 m | 858.0 m | 384.0 m | 876.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Long-term debt | 2.1 bn | 2.4 bn | 2.3 bn | 1.8 bn | 1.9 bn | 1.9 bn | SEC (XBRL)· 11 Mar 2026verified |
| Current liabilities | 2.2 bn | 2.6 bn | 2.6 bn | 2.6 bn | 2.3 bn | 3.1 bn | SEC (XBRL)· 11 Mar 2026verified |
| Total liabilities | 5.6 bn | 6.3 bn | 6.0 bn | 5.6 bn | 5.3 bn | 6.2 bn | SEC (XBRL)· 11 Mar 2026verified |
| Equity | 4.1 bn | 4.7 bn | 5.7 bn | 6.0 bn | 6.0 bn | 6.2 bn | SEC (XBRL)· 11 Mar 2026verified |
| Shares outstanding at year end | 1.3 bn | 1.3 bn | 1.3 bn | 1.3 bn | 1.3 bn | 1.3 bn | SEC (XBRL)· 11 Mar 2026verified |
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 804.0 m | 1.1 bn | 2.1 bn | 1.7 bn | 1.5 bn | 1.1 bn | SEC (XBRL)· 11 Mar 2026verified |
| Investing cash flow | -583.0 m | -579.0 m | -747.0 m | -853.0 m | -694.0 m | -915.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Financing cash flow | -105.0 m | -244.0 m | -1.4 bn | -837.0 m | -846.0 m | -195.0 m | SEC (XBRL)· 11 Mar 2026verified |
| Dividends paid | 118.0 m | 276.0 m | 1.2 bn | 474.0 m | 251.0 m | 224.0 m | SEC (XBRL)· 11 Mar 2026verified |
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
Risk
Valuation
olivLaw classification
Score: 40 / 100
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 5.9 bn USD
Key indicators
Coverage and freshness
Score by group
- Balance sheet41
- Valuation49
- Quality64
- Growth0
- Returns54
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 1.09 – 7.37 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDA2.66 – 7.37 (Mid 4.59)4 companies used · median multiple 6.4x · quartiles 4.5x – 9.2xCF, MOS, NTR, UAN
- Peers: P/E1.09 – 2.20 (Mid 1.72)4 companies used · median multiple 9.5x · quartiles 6.0x – 12.2xCF, EVGN, NTR, UAN
- Dividend discount (DDM)2.28 – 3.07 (Mid 2.62)
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Neutral profile · Score 40/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 4.4% | 60 (vs peers) | 13% |
| Net margin · Quality | 3.2% | 70 (vs peers) | 8% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -10.6% | 0 (on a fixed band) | 10% |
| EPS CAGR 3Y · Growth | -52.4% | 0 (on a fixed band) | 10% |
| Net debt / EBITDA · Balance sheet | 1.9x | 60 (on a fixed band) | 13% |
| Interest coverage · Balance sheet | 1.9x | 7 (on a fixed band) | 8% |
| Current ratio · Balance sheet | 1.3x | 44 (on a fixed band) | 5% |
| P/E (TTM) · Valuation | 25.4x | 20 (vs peers) | 13% |
| EV/EBITDA · Valuation | 6.4x | 78 (on a fixed band) | 13% |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | 3.8% | 54 (on a fixed band) | 8% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet41/100 · 3/3 factors with a value
- Growth0/100 · 2/2 factors with a value
- Quality64/100 · 2/3 factors with a value
- Returns· partial54/100 · 1/2 factors with a value
- Valuation49/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
ICL GROUP LTD. (ICL). Latest full fiscal year: 2025; data up to 2025-12-31.
Figures computed from the financial statements: revenue 7.2 bn USD in 2025; YoY growth 4.6%; net margin 3.2%; ROE 3.9%; net debt/EBITDA 1.9x.
The estimated value range is 2.28–3.07 USD per share (median of 3 methods, agreement: low); assumptions are illustrative. Against the central value of 2.62 USD, the price of 4.58 USD leaves a potential of -42.9% (value / price − 1) and a margin of safety of -75.1% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 40/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: returns. Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Net margin: 3.2%
- EV/EBITDA: 6.4x
What contradicts it
- Revenue CAGR 3Y: -10.6%
- EPS CAGR 3Y: -52.4%
- Interest coverage: 1.9x
- P/E (TTM): 25.4x
- The price is above the estimated value range
- The valuation methods diverge
Not assessed (insufficient data or a ratio without meaning): FCF conversion, FCF yield, Payout ratio (FCF).
Versus the vertical median
Agricultural Chemicals (SIC 2870) · same industry (4-digit SIC) · compared with 10 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| NTRNutrien Ltd. | 41.0 bn | 15.5 | 9.1% | 8.4% | +3.5% | +24% / +35% |
| CFCf Industries Holdings, Inc. | 16.9 bn | 7.9 | 46.7% | 32.3% | +19.3% | +42% / +49% |
| MOSMosaic Co | 6.9 bn | — | -9.3% | -9.4% | +8.4% | −12% / −40% |
| ICLIcl Group Ltd. | 5.9 bn | 25.4 | 3.9% | 3.2% | +4.6% | −31% / −8% |
| SMGScotts Miracle-Gro Co | 3.9 bn | 55.8 | — | 2.1% | −3.9% | +19% / +21% |
| UANCvr Partners, LP | 1.2 bn | 11.1 | — | 16.1% | +15.4% | +16% / +64% |
| AVDAmerican Vanguard Corporation | 28.8 m | — | -26.5% | -10.7% | −5.9% | −79% / −90% |
| BIOXBioceres Crop Solutions Corp. | 16.2 m | — | -19.1% | -16.5% | −27.9% | −85% / −98% |
| SNESSenestech, Inc. | 6.6 m | — | -107.4% | -294.7% | +19.6% | −58% / −87% |
| CBUSCibus, Inc. | 6.2 m | — | -225.9% | -2,258.9% | −14.6% | −9% / −90% |
| EVGNEvogene Ltd. | 3.1 m | 0.3 | — | -220.2% | −30.9% | −66% / −95% |
1- and 3-year price returns: for ICL from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 2.38 Total return -45% · Per year -45% | 4.23 Total return -4% · Per year -4% | 6.40 Total return 44% · Per year 44% |
| 3 years | 1.89 Total return -52% · Per year -22% | 3.82 Total return -7% · Per year -2% | 6.40 Total return 53% · Per year 15% |
| 5 years | 1.50 Total return -57% · Per year -15% | 3.45 Total return -9% · Per year -2% | 6.40 Total return 61% · Per year 10% |
- Exit P/E± 0.95
- Net margin± 0.67
- Annual revenue growth± 0.60
- Annual dilution± 0.06
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 11 Mar 2026; since then the company filed 6-K (17 Sept 2026), 6-K (01 Sept 2026), 6-K (05 Aug 2026).
In brief
ICL Group Ltd. is a global leader in agriculture, food and industrial solutions, built on its own mineral resources in the Dead Sea, Spain, Israel and the United Kingdom 1. The company focuses on specialty agriculture and food businesses, at a time when food security and access to essential minerals remain central themes 1. Total sales for fiscal 2025 were 7153 million USD 1.
SWOT
Strengths
Weaknesses
Opportunities
- Growth in the specialty fertilizer market could support expansion of the Growing Solutions segment 1.
- Recent acquisitions in biologicals and food ingredients, such as Bartek Ingredients, could open new revenue lines 1.
- LFP battery raw materials through the China joint venture could add growth outside agriculture 1.
Threats
- The new Dead Sea concession process could lead to less favorable terms or loss of the concession 1.
- Environmental regulation and climate change could raise costs and required investment 1.
- Currency fluctuations and international restrictions could affect results and the distribution of cash to shareholders 1.
Risks
- Dead Sea concessionhigh
The concession expires in March 2030, and a new concession could be granted on less favorable terms or might not be obtained at all 1.
- Concession billhigh
The draft bill published in December 2025 is only an initial stage, and the final law could differ materially from the current version 1.
- Mining and phosphate permitsmedium
Renewal of certain leases and extraction permits is not certain, and new terms could be more restrictive 1.
- Environmental and climate regulationmedium
Changes in environmental law could require substantial capital expenditure and affect operating performance 1.
- Currency and financing risklow
As a multinational, results could be affected by currency fluctuations and by access to capital markets for refinancing 1.
Investment thesis
What would need to be true (bull case)
- If demand for specialty fertilizers grows as estimated, the Growing Solutions segment could contribute an increasing share of revenue and margins 1.
- A leading position in low-cost mineral resources could support profitability even in periods of lower prices 1.
- Recent food and biologicals acquisitions could diversify revenue away from agricultural cycles 1.
What would break the thesis
- The risk of losing the Dead Sea concession after 2030 could seriously affect the company's most valuable assets 1.
- If grain prices fall or volatility rises, revenue in the commodity segments could decline significantly 1.
- Environmental requirements and remediation costs could reduce profit and limit the ability to distribute dividends 1.
What to watch
- Quarterly results and guidance for the Phosphate Solutions segmentQ1 2027
- Progress of the Dead Sea concession tender and the final version of the law2027
- Sales trend in Growing Solutions after the Brazil and North America acquisitionsnext 10-K
- Integration of Bartek Ingredients and its impact on margins2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 11 Mar 2026; since then the company filed 6-K (17 Sept 2026), 6-K (01 Sept 2026), 6-K (05 Aug 2026).
The business
ICL organizes its activity into four segments: Industrial Products (bromine), Potash, Phosphate Solutions and Growing Solutions 1. The company says it is a leader in each of these value chains, either by market share or cost competitiveness 1. Its principal assets include access to one of the world's richest and lowest-cost sources of potash and bromine, in the Dead Sea, and a global logistics network in over 30 countries 1. In January 2026 ICL acquired 49.9% of Bartek Ingredients, a producer of food-grade malic and fumaric acids 1.
Fiscal 2025 sales were 7153 million USD, with operating income of 580 million USD and adjusted operating income of 873 million USD 1. Net income attributable to shareholders was 226 million USD and adjusted net income was 465 million USD 1. The gap between reported and adjusted figures shows that accounting results are affected by items the company separates in its reporting 1.
The shareholder base is concentrated: Israel Corp. held approximately 43.11% of outstanding ordinary shares as of December 31, 2025 1. The company is listed in New York and Tel Aviv and operates as a limited liability company under Israeli law 1.
Segments
Phosphate Solutions
The largest segment by sales in 2025, with sales of 2333 million USD and operating profit of 342 million USD 1. It includes specialty phosphates for the food industry, as well as fertilizers and raw materials for LFP batteries through the YPH joint venture in China 1.
Market context
The company ties its strategy to three global mega trends: food availability, access to mineral resources and deglobalization 1. World population is expected to grow from 8 billion in 2024 to 9.7 billion by 2050, according to the UN, which could support fertilizer demand 1. The specialty fertilizer market is estimated to grow at a CAGR of 6.5% from 2025 to 2030, faster than the conventional market 1.
Short-term demand is volatile and seasonal, depending on weather, crop prices and government policies 1. The company expects the long-term upward trend in fertilizer markets to be maintained, but short-term results depend on crop cycles 1.
Trends
- Rising protein consumptiontailwind
Income growth in emerging markets could shift diets toward more protein, requiring more grain for livestock and, in turn, more fertilizer 1.
- Shrinking arable land per capitatailwind
If new arable land remains limited, production growth could depend on higher yields, which could favor optimized potash and specialty fertilizer use 1.
- Environmental rules on nutrientsmixed
Regulations such as the EU Nitrate Directive limit nutrient use, which could push growers toward efficient solutions like controlled release fertilizers 1.
- Grain price volatilityheadwind
Corn, wheat and rice prices fell in 2025, while low stock levels could lead to sharp price increases if unusual weather occurs 1. This volatility could affect commodity segment revenue 1.
Competitive position
The sources mention competition from some of the world's largest chemical and mining companies, as well as mergers among key producers, customers and suppliers 1. The company claims leading positions by market share or cost in each segment 1.
In specialty fertilizers, competition also comes from biological and efficiency-focused producers, while in potash and phosphates it is driven by extraction costs and resource access 1. The sources do not give exact market shares for competitors 1.
- Large global chemical and mining companies
Competition described generically in the annual report, without explicit names in the source text 1.
- Potash and phosphate producers
The source cites pressure from high-volume producers without naming them 1.
- Agricultural biologicals suppliers
Competition in biologicals, where the company expanded through its Brazilian acquisition 1.
- Regional fertilizer distributors and producers
The company notes rivalry in Asian and Latin American markets without naming them in the source 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report (foreign issuer)17 Sept 2026
- Current report (foreign issuer)01 Sept 2026
- Current report (foreign issuer)05 Aug 2026
- Current report (foreign issuer)05 Aug 2026
- Current report (foreign issuer)05 Aug 2026
- Current report (foreign issuer)05 Aug 2026
- Current report (foreign issuer)30 Jul 2026
- Current report (foreign issuer)30 Jun 2026
- Current report (foreign issuer)23 Jun 2026
- Current report (foreign issuer)16 Jun 2026
Sources
- [1] Form 20-F, fiscal year ended 2025-12-31 · SEC / ICL Group Ltd. · 11 Mar 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.